Advertisement

Acta Neuropathologica

, Volume 75, Issue 1, pp 8–15 | Cite as

Diffuse Lewy body disease

Neuropathological and biochemical studies of six patients
  • D. W. Dickson
  • P. Davies
  • R. Mayeux
  • H. Crystal
  • D. S. Horoupian
  • A. Thompson
  • J. E. Goldman
Regular Papers

Summary

Post-mortem pathological and biochemical studies are reported on six patients with progressive dementia. The characteristic pathological finding was neurofilament-containing cytoplasmic inclusions in cortical and subcortical neurons. The clinical and pathological findings were consistent with so-called diffuse Lewy body disease. The patients had variable changes of the Alzheimer type, with five of six patients displaying “plaques only” Alzheimer's changes. Biochemical studies showed profound decreases in neocortical choline acetyltransferase (ChAT) activities that correlated with marked neuronal loss in the basal nucleus of Meynert. ChAT activities were normal in the hippocampus in three patients who also had no significant Alzheimer type hippocampal changes. All patients had decreased cortical somatostatin-like immunoreactivity. Our observations suggest that dementia in diffuse Lewy body disease bears biochemical similarities to Alzheimer's disease, in that biochemical markers for both intrinsic cortical neurons and ascending cholinergic neurons are affected.

Key words

Choline acetyltransferase Lewy body Parkinson's disease Somatostatin Thioflavine S 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ball MJ (1984) The morphological basis of dementia in Parkinson's disease. Can J Neurol Sci 11:180–184Google Scholar
  2. 2.
    Ball MJ, Hachinski V, Fox A, Kirshen AJ, Fisman M, Blume W, Kral VA, Fox H (1985) Alzheimer's disease: a new definition. A hippocampal dementia. Lancet 1:14–16Google Scholar
  3. 3.
    Beal MJ, Mazurek MF, Martin JB (1986) Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes. Brain Res 397:386–388Google Scholar
  4. 4.
    Beal MF, Mazurek MF, Svendsen CN, Bird ED, Martin JB (1986) Widespread reduction of somatostatin-like immunoreactivity in cerebral cortex in Alzheimer's disease. Ann Neurol20:489–495Google Scholar
  5. 5.
    Boller F (1985) Parkinson's disease and Alzheimer's disease: are they associated? In: Hulton JT, Kenny AD (eds) Senile dementia of the Alzheimer type. Alan R. Liss New York, pp 243–261Google Scholar
  6. 6.
    Burkhardt C, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA (1987) Diffuse Lewy body disease and progressive dementia. Neurology [Suppl 1] 37:331 (abstr)Google Scholar
  7. 7.
    Byrne EJ, Lowe J, Godwin-Austin RB, Aire T, Jones R (1987) Dementia and Parkinson's disease associated with diffuse cortical Lewy bodies. Lancet I:501Google Scholar
  8. 8.
    Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA (1986) The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. In: Swaab DF, Fliers E, Mirmiran M, Van Gool WA, Van Hagren F (eds) Aging of the brain and Alzheimer's disease. Prog Brain Res 70:105–132Google Scholar
  9. 9.
    Chui HC, Mortimer JA, Slager U, Barrow C, Bondareff W, Webster DD (1986) Pathological correlates of dementia in Parkinson's disease. Arch Neurol 43:991–995Google Scholar
  10. 10.
    Davies P (1979) Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 171:319–327Google Scholar
  11. 11.
    Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet II: 1403Google Scholar
  12. 12.
    Davies P, Terry RD (1981) Cortical somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's disease and senile dementia of the Alzheimer type. Neurobiol Aging 2:9–14Google Scholar
  13. 13.
    Delfs TR (1985) Somatostatin and Alzheimer's disease: possible pathophysiological associations. In: Hulton JT, Kenny AD (eds) Senile dementia of the Alzheimer type Alan R. Liss New York, pp 243–261Google Scholar
  14. 14.
    Dickson DW, Yen S-H, Suzuki KI, Davies P, Garcia F, Hirano A (1986) Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol (Berl) 71:216–223Google Scholar
  15. 15.
    Epelbaum J, Ruberg M, Moyse E, Javoy-Agid F, Dubois B, Agid Y (1983) Somatostatin and dementia in Parkinson's disease. Brain Res 278:376–379Google Scholar
  16. 16.
    Ezrin-Waters C, Resch L (1986) The nucleus basalis of Meynert Can J Neurol Sci 13:8–14Google Scholar
  17. 17.
    Forno LS, Sternberger LA, Sternberger NH, Strefling AM, Swanson K, Eng LF (1986) Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments. Neurosci Lett 64:253–258Google Scholar
  18. 18.
    Gaspar P, Gray F (1984) Dementia in idiopathic Parkinson's disease: a neuropathological study of 32 cases. Acta Neuropathol (Berl) 64:43–52Google Scholar
  19. 19.
    Goldman JE, Yen S-H, Chiu F-C, Peress NS (1983) Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221:1082–1084Google Scholar
  20. 20.
    Ikeda K, Ikeda S, Yoshimura T, Kato H, Namba M (1978) Idiopathic parkinsonism with Lewy-type inclusions in the cerebral cortex. A case report. Acta Neuropathol (Berl) 41:165–168Google Scholar
  21. 21.
    Jolkkonen J, Soininen H, Halonen T, Ylinen A, Laulumaa V Laakso M, Riekkinen P (1986) Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation of dementia. J Neurol Neurosurg Psychiatry 49:1374–1377Google Scholar
  22. 22.
    Joynt RJ, McNeill TH (1984) Neuropeptides in aging and dementia. Peptides [Suppl 1] 5:269–274Google Scholar
  23. 23.
    Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: progressive dementia and abundant cortical Lewy bodies and senile changes of varying degree — a new disease? Clin Neuropathol 3:185–192Google Scholar
  24. 24.
    Ksiezak-Reding H, Yen S-H (1987) Two monoclonal antibodies recognize Alzheimer's neurofibrillary tangles, neurofilaments, and microtubule-associated proteins. J Neurochem 48:455–462Google Scholar
  25. 25.
    Leverenz J, Sumi SM (1986) Parkinson's disease in patients with Alzheimer's disease. Arch Neurol 43:662–664Google Scholar
  26. 26.
    McKinney M, Davies P, Coyle JT (1982) Somatostatin is not co-localized in cholinergic neurons innervating the rat cerebral cortex-hippocampal formation. Brain Res 243: 169–172Google Scholar
  27. 27.
    Mesulam M-M, Van Hoesen GW (1976) Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex. Brain Res 109:152–157Google Scholar
  28. 28.
    Morrison JH, Benoit R, Magistretti PJ, Bloom FE (1983) Immunohistochemical distribution of pro-somatostatinrelated peptides in cerebral cortex. Brain Res 262:344–351Google Scholar
  29. 29.
    Nakano I, Hirano A (1983) Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease. Ann Neurol 15:415–418Google Scholar
  30. 30.
    Ohama E, Ikuta F (1976) Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol (Berl) 43:311–319Google Scholar
  31. 31.
    Okazaki H, Lipkin LE, Aronson SM (1961) Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 3:237–244Google Scholar
  32. 32.
    Perry RH, Tomlinson BE, Candy JM, Blessed G, Foster JF, Bloxham CA, Perry ER (1983) Cortical cholinergic deficit in mentally impaired Parkinsonian patients. Lancet II: 789–790Google Scholar
  33. 33.
    Rajput AH, Offord K, Beard CM, Kurland LT (1984) Epidemiological survey of dementia in Parkinsonism and control population. In: Hassler RG, Christ JF (eds) Parkinson-specific motor and mental disorders: role of the pallidum: pathophysiological biochemical and therapeutic aspects. Raven Press, New York pp 229–234Google Scholar
  34. 34.
    Schwartz (1972) Amyloid degeneration and tuberculosis in the aged. Gerontologia 18:321–362Google Scholar
  35. 35.
    Sima AAF, Clark AW, Sternberger NA, Sternberger LA (1986) Lewy body dementia without Alzheimer changes. Can J Neurol Sci 13:490–497Google Scholar
  36. 36.
    Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R (1987) Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 46:262–268Google Scholar
  37. 37.
    Ulrich J (1985) Alzheimer changes in nondemented patients younger than 65: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann Neurol 17: 273–277Google Scholar
  38. 38.
    Wilcock GK, Esiri MM, Bowen DM, Smith CCT (1982) Alzheimer's disease: correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 57:407–417Google Scholar
  39. 39.
    Whitehouse PJ, Hedreen JC, White CL III, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 13:243–248Google Scholar
  40. 40.
    Wisniewski HM, Merz GS (1985) Neuropathology of the aging brain and dementia of the Alzheimer type. In: Gaitz CM, Samorajski T (eds) Aging 2000: our health care destiny, vol 1, biomedical issues. Springer, New York Berlin Heidelberg pp 231–243Google Scholar
  41. 41.
    Wisniewski HM, Terry RD (1973) Re-examination of the pathogenesis of the senile plaque. In: Zimmerman HM (ed) Progress in neuropathology, vol 2. Grune and Stratton New York, pp 1–26Google Scholar
  42. 42.
    Wolozin BL, Pruchnicki A, Dickson DW, Davies P (1986) A neuronal antigen in the brain of patients with Alzheimer's disease. Science 232:648–650Google Scholar
  43. 43.
    Yoshimura M (1983) Cortical changes in the parkinsonian brain: a contribution to the delineation of “diffuse Lewy body disease”. J Neurol 229:17–32Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • D. W. Dickson
    • 1
  • P. Davies
    • 1
  • R. Mayeux
    • 3
  • H. Crystal
    • 2
  • D. S. Horoupian
    • 4
  • A. Thompson
    • 1
  • J. E. Goldman
    • 1
  1. 1.Department of Pathology (Neuropathology) and Rose F. Kennedy Center for Research in Mental Retardation and Human DevelopmentBronxUSA
  2. 2.Department of NeurologyAlbert Einstein College of MedicineBronxUSA
  3. 3.Department of Neurology and PsychiatryColumbia UniversityNew YorkUSA
  4. 4.Department of PathologyStanford UniversityStanfordUSA

Personalised recommendations